Jon Akutagawa

Also affiliated with University of California, Santa Cruz, UCSF Helen Diller Family Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment”.

The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment

Haematologica(2021)10.3324/haematol.2020.261354

N/A

0DataRank · unranked

11 citations

Jonathan V. Nguyen, Adrian Stecula, Jon Akutagawa, Anthony V. Moorman, Benjamin S. Braun +9 more

Identification of cancer drivers from tumor-only RNA-seq with RNA-VACAY

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.10.491431

N/A

0DataRank · unranked

1 citations

Allysia J. Mak, Julie L. Aspden, Angela N. Brooks, Jon Akutagawa